美國帕金森氏症腦深部刺激市場規模、佔有率和趨勢分析報告：按產品、細分市場預測，2024-2030年

美國帕金森氏症腦深部刺激市場的成長和趨勢

根據Grand View Research, Inc.最新報告，預計2030年美國帕金森氏症腦深部刺激市場規模將達到8.495億美元，2024年至2030年複合年成長率為7.29%。

該市場受到新產品發布和醫療保健支出增加等多種因素的推動。增加監管核准是推動市場成長的關鍵，因為它為醫療保健專業人員和患者提供了有關這些設備的安全性和有效性的一定程度的保證，從而促進在臨床實踐中的採用發揮著重要作用。例如，2024 年 1 月，FDA 批准了 Abbott 的 Liberta RC DBS 設備，這是推動 PD治療性介入介入的重要里程碑。

Liberta RC DBS 被認為是同類產品中最小的可充電 DBS 設備，並引入了顯著的技術功能，例如支援遠端程式設計功能的 NeuroSphere Virtual Clinical。此次監管核准強調了該設備遵守嚴格的安全性和有效性標準，並將其定位為神經調節領域的開創性解決方案。 Abbott 在 Liberta RC DBS 上納入遠端程式設計功能在策略上符合當前的醫療趨勢，增加了患者的便利性並擴大了醫療界對該設備的接受度。

Abbott 最近 FDA 批准 Liberta RC DBS 預計將帶來市場動態的變革，並推動美國DBS 領域對 PD 治療的興趣和採用。

美國帕金森氏症市場腦深部刺激報告亮點

• 預計從 2024 年到 2030 年，雙通道細分市場的複合年成長率將達到 7.87%。
• 這一成長得益於行業主要企業的技術進步和新產品的推出。
• 推動市場成長的主要因素之一是監管機構擴大核准用於帕金森氏症 (PD) 治療的深部腦部刺激 (DBS) 設備。
• 監管部門的核准為製造商提供了行銷和商業化其設備的機會，並增加了競爭。
• 這種競爭可能會帶來技術進步和設備設計的改進，從而帶來更具成本效益的選擇，進一步促進市場成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國帕金森氏症市場的深部腦部刺激變數、趨勢和範圍

• 市場體系展望
  • 配套市場前景
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
  • 市場機會分析
  • 市場問題分析
• 美國巴金森氏症腦深部刺激市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章美國帕金森氏症腦深部刺激市場：產品預估及趨勢分析

• 細分儀表板
• 美國巴金森氏症腦深部刺激市場波動分析
• 2018-2030年美國巴金森氏症腦深部電刺激市場規模及趨勢分析（分產品）
• 單通道
• 雙通道

第5章競爭狀況

• 市場參與企業分類
• 主要企業簡介
  • ABBOTT
  • Medtronic
  • Boston Scientific Corporation
• 熱圖分析/企業市場分析
• 2023年企業市場佔有率評估分析
• 其他主要市場參與者名單

U.S. Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The U.S. deep brain stimulation in parkinson's disease market size is anticipated to reach USD 849.50 million by 2030, registering a CAGR of 7.29% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by various factors, such as novel product launches, and rising healthcare expenditure. Increasing regulatory approvals play a crucial role in driving market growth as they provide a level of assurance to healthcare professionals and patients regarding the safety and efficacy of these devices, thereby encouraging their adoption in clinical practice. For instance, in January 2024, FDA clearance for Abbott's Liberta RC DBS Device represented a significant milestone in advancing therapeutic interventions for PD.

Liberta RC DBS, distinguished as the smallest rechargeable DBS device in its class, introduced notable technological features, such as the NeuroSphere Virtual Clinical, enabling remote programming capabilities. This regulatory endorsement underscored adherence of the device to stringent safety and efficacy standards and positioned it as a pioneering solution in the field of neuromodulation. The incorporation of remote programming capabilities in the Liberta RC DBS device by Abbott aligns strategically with prevailing healthcare trends, augmenting patient convenience and broadening the device's acceptance within the medical community.

Abbott's recent achievement of securing FDA clearance for Liberta RC DBS is anticipated to catalyze transformative shifts in market dynamics, propelling heightened interest and fostering increased adoption within the U.S. DBS sector for PD treatment.

U.S. Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

• The dual-channel segment is expected to register the fastest CAGR of 7.87% from 2024 to 2030
• This growth is attributed to technological advancements and novel product launches by industry key players
• One of the key factors driving the market growth is increasing regulatory approval for deep brain stimulation (DBS) devices in Parkinson's disease (PD) treatment
• Regulatory approvals offer opportunities for manufacturers to market and commercialize their devices, fostering competition
• This competition often results in technological advancements, device design improvements, and potentially more cost-effective options, which further contribute to market growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements In Deep Brain Stimulation Devices
    • 3.2.1.2. Increasing Prevalence Of Parkinson's Disease
    • 3.2.1.3. Government Funding For Research And Development
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex Regulatory Framework
    • 3.2.2.2. Risk And Complications Associated With DBS Surgery
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Increasing Clinical Studies On DBS Assessments For Parkinson's Disease
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Alternatives For DBS System
• 3.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Deep Brain Stimulation In Parkinson's Disease Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Deep Brain Stimulation In Parkinson's Disease Market Movement Analysis
• 4.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Single-Channel
  • 4.4.1. Single-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Dual-Channel
  • 4.5.1. Dual-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Key Company Profiles
  • 5.2.1. ABBOTT
    • 5.2.1.1. Company Overview
    • 5.2.1.2. Financial Performance
    • 5.2.1.3. Service Benchmarking
    • 5.2.1.4. Strategic Initiatives
  • 5.2.2. Medtronic
    • 5.2.2.1. Company Overview
    • 5.2.2.2. Financial Performance
    • 5.2.2.3. Service Benchmarking
    • 5.2.2.4. Strategic Initiatives
  • 5.2.3. Boston Scientific Corporation
    • 5.2.3.1. Company Overview
    • 5.2.3.2. Financial Performance
    • 5.2.3.3. Service Benchmarking
    • 5.2.3.4. Strategic Initiatives
• 5.3. Heat Map Analysis/ Company Market Position Analysis
• 5.4. Estimated Company Market Share Analysis, 2023
• 5.5. List of Other Key Market Players

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market, by Product, 2018 - 2030 (USD Million)
• Table 4. Participant's Overview
• Table 5. Financial Performance
• Table 6. Product Benchmarking
• Table 7. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Deep Brain Stimulation In Parkinson's Disease Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Product Marketplace: Key Takeaways
• Fig. 14 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Single-channel, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Dual-channel, 2018 - 2030 (USD Million)